[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100330747":3},{"organization":4,"armGroups":7,"interventions":21,"overallOfficials":36,"centralContacts":41,"locations":47,"responsibleParty":63,"collaborators":27,"id":65,"slug":66,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":71,"eligibilityCriteria":72,"healthyVolunteers":73,"sex":74,"minAge":75,"maxAge":27,"enrollmentInfo":76,"targetDuration":27,"studyType":79,"phases":80,"briefSummary":82,"conditions":83,"keywords":88,"overallStatus":50,"whyStopped":27,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"University Hospital, Caen","OTHER",[8,16],{"label":9,"type":10,"description":11,"interventionNames":12},"Brain Damaged Subjects","EXPERIMENTAL","Patients with circumscribed brain injury, developmental pathology or degenerative pathology responsible for selective cognitive disorders",[13,14,15],"Behavioral: Neuropsychological testing","Other: Brain Imaging","Other: Galvanic Vestibular Stimulation (GVS)",{"label":17,"type":18,"description":19,"interventionNames":20},"Healthy Volunteers","SHAM_COMPARATOR","Healthy Controls",[13,14,15],[22,28,32],{"type":23,"name":24,"description":25,"armGroupLabels":26,"otherNames":27},"BEHAVIORAL","Neuropsychological testing","Experimental test about cognitive deficit of interest and standard neuropsychological tests",[9,17],null,{"type":6,"name":29,"description":30,"armGroupLabels":31,"otherNames":27},"Brain Imaging","Anatomical, diffusion, and\u002For functional MRI",[9,17],{"type":6,"name":33,"description":34,"armGroupLabels":35,"otherNames":27},"Galvanic Vestibular Stimulation (GVS)","Stimulation versus Sham",[9,17],[37],{"name":38,"affiliation":39,"role":40},"Olivier MARTINAUD, MD, PhD","Caen University Hospital, Normandie UNIV, UNICAEN, PSL Research University, EPHE, Inserm, U1077, CHU de Caen, Neuropsychologie et Imagerie de la Mémoire Humaine, 14000 Caen, France","PRINCIPAL_INVESTIGATOR",[42],{"name":38,"role":43,"phone":44,"phoneExt":45,"email":46},"CONTACT","2 31 06 46 17","+33","martinaud-o@chu-caen.fr",[48],{"facility":49,"status":50,"city":51,"state":27,"zip":52,"country":53,"countryCode":54,"cosmosGeoPoint":55,"geoPoint":60,"contacts":61},"Caen University Hospital","RECRUITING","Caen","14000","France","FR",{"type":56,"coordinates":57},"Point",[58,59],-0.35912,49.18585,{"lat":59,"lon":58},[62],{"name":38,"role":43,"phone":44,"phoneExt":45,"email":46},{"type":64,"investigatorFullName":27,"investigatorTitle":27,"investigatorAffiliation":27,"oldNameTitle":27,"oldOrganization":27},"SPONSOR","100330747","neuropsychological-and-brain-medical-imaging-study-in-patients-with-brain-damage-2-100330747",false,"NCT03586258","Neuropsychological and Brain Medical Imaging Study in Patients With Brain Damage 2","Anatomical Clinical Correlations. Neuropsychological and Brain Medical Imaging Study in Brain Damage Subjects 2 (CORAC2)","CORAC2","Inclusion Criteria:\n\n* Age \\> 17 years\n* French language\n* Effective contraception for women during the study\n* Informed consent\n* No alcohol intake the day before the exam\n* For patients only, focal cerebral lesion (stroke, malformation, tumor, inflammatory, infectious, traumatic), neonatal pathology, developmental or degenerative disease with cognitive deficit\n\nExclusion Criteria:\n\n* For healthy volunteers: previous neurological history (except non complicated migraine or epilepsy), previous psychiatric history (except depression with good evolution or anxiety), or severe cranial traumatism\n* For patients: vigilance disorders, severe depression or anxiety.\n* For both: psychotropic medication other than a hypnotic or an anxiolytic at low doses without dose modification for at least one month, severe visual or auditory impairment, patient without judicial or administrative liberty, measure of legal protection or no capable to express their consent, pregnancy or breastfeeding, contraindication for MRI or GVS if applicable, participation in another trial or former involvement in another trial within one month.",true,"ALL","18 Years",{"count":77,"type":78},400,"ESTIMATED","INTERVENTIONAL",[81],"NA","Two groups of subjects will be constitute: (i) patients with circumscribed brain injury (including stroke, vascular malformations, tumor or circumscribed infectious lesions) or degenerative\u002Fdevelopmental disorders and selective cognitive disorders; (ii) healthy control subjects.\n\nThe objective of this project is to evaluate specific neuropsychological deficits and apply current brain imaging techniques (anatomical, diffusion, functional, magnetic stimulation) to patients suffering from these cognitive deficits due to brain damage, in order to elucidate the brain mechanisms underlying these deficits.",[84,85,86,87],"Cerebrovascular Disorders","Brain Lesion","Degenerative Disease","Developmental Disability",[89,90],"Neuropsychological study","Brain imaging","2026-04-09",{"date":93,"type":94},"2026-04-13","ACTUAL",{"date":96,"type":94},"2019-01-10",{"date":98,"type":78},"2030-06",{"name":5,"class":6},1]